- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.01. | Autonomous AI can spot cognitive decline in medical notes | ||
| 16.01. | Trump's affordability plan arrives, built around MFN pricing | ||
| 15.01. | J&J builds case for earlier Tecvayli use in multiple myeloma | ||
| 15.01. | Novartis issues a life sciences warning in a 'G-Zero' world | ||
| 15.01. | Novo Nordisk Foundation pledges €736m for European biotech | ||
| 15.01. | EMA and FDA agree 'principles' for AI in drug development | ||
| 15.01. | Oxford BioMedica confirms private equity takeover talks | ||
| 14.01. | JPM: Novo Nordisk CEO gives insight into new strategy | ||
| 14.01. | FDA seeks changes to GLP-1, flu shot labels | ||
| 14.01. | Hippocratic AI builds in life sciences with Grove AI buy | ||
| 14.01. | JPM: Illumina launches 'unprecedented' disease biology atlas | ||
| 14.01. | UK names health data chief, as BIA finds its new CEO | ||
| 13.01. | JPM: Anthropic reveals its answer to ChatGPT for Health | ||
| 13.01. | Sentynl gets first FDA approval for rare disease Menkes | ||
| 13.01. | AbbVie turbocharges its US investment promise to $100bn | ||
| 13.01. | JPM: Is the UK's clinical trials sector turning a corner? | ||
| 12.01. | JPM: AbbVie pays $650m upfront for RemeGen cancer drug | ||
| 12.01. | FDA removes barriers to cell, gene therapy development | ||
| 12.01. | Abivax climbs on Lilly takeover speculation | ||
| 12.01. | Madrigal eyes combination MASH therapy with Pfizer deal | ||
| 12.01. | Perlmutter's Eikon follows the IPO trail | ||
| 09.01. | J&J jumps on the MFN pricing train | ||
| 09.01. | FDA turns down Hetlioz for jet lag once again | ||
| 09.01. | Now Iktos teams up with Pierre Fabre in oncology | ||
| 09.01. | Parabilis scores $305m in bumper biofinancing week |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.